VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RVP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RVPRetractable Technologies, Inc.
$0.70$21M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRVPFinancials

Retractable Technologies, Inc. (RVP) Financials

26Y historyFree accessUpdated daily

The company's profitability is severely constrained by a gross margin that plummeted to 0.3% in 2026Q1, reflecting an inability to achieve operating leverage against a -85.9% operating margin.

RVP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Sales/Revenue37.15M38.27M33.05M43.6M94.82M188.38M81.86M41.8M33.27M34.49M29.83M29.55M34.52M30.79M33.64M32.1M36.22M38.98M27.9M26.29M25.32M24.24M21.52M19.08M20.32M16.15M9.64M
Revenue Growth %10.08%15.78%-24.19%-54.02%-49.67%130.12%95.86%25.61%-3.53%15.65%0.93%-14.39%12.13%-8.5%4.8%-11.37%-7.09%39.72%6.12%3.81%4.5%12.61%12.81%-6.09%25.83%67.46%-
Cost of Goods Sold37.07M38.22M34.08M34.49M66.57M93.03M44.85M27.66M23.05M24.52M19.48M18.99M22.5M20.48M22.47M21.2M23.82M25.47M19.67M18.3M17.78M15.43M16.41M14.65M14.99M13.32M7.88M
COGS % of Revenue-99.88%103.11%79.11%70.2%49.38%54.79%66.17%69.28%71.09%65.33%64.25%65.18%66.51%66.78%66.04%65.75%65.33%70.51%69.61%70.2%63.66%76.25%76.81%73.79%82.52%81.7%
Gross Profit73.59K47.05K-1.03M9.11M28.25M95.35M37.01M14.14M10.22M9.97M10.34M10.57M12.02M10.31M11.18M10.9M12.4M13.52M8.23M7.99M7.55M8.81M5.11M4.42M5.33M2.82M1.76M
Gross Margin %0.2%0.12%-3.11%20.89%29.8%50.62%45.21%33.83%30.72%28.91%34.67%35.75%34.82%33.49%33.22%33.96%34.25%34.67%29.49%30.39%29.8%36.34%23.75%23.19%26.21%17.48%18.3%
Gross Profit Growth %-104.58%-111.29%-67.76%-70.37%157.65%161.77%38.31%2.51%-3.58%-2.11%-12.12%16.6%-7.75%2.51%-12.11%-8.23%64.31%2.96%5.87%-14.31%72.3%15.52%-16.92%88.66%60.01%-
Operating Expenses22.74M20.27M20.08M20.6M29.11M22.76M12.94M11.17M11.8M13.75M13.39M13.77M14.18M16.24M15.12M14.99M18.82M24.22M18.67M17.94M14.26M11.68M13.11M10.33M11.23M9.54M11.27M
OpEx % of Revenue-52.97%60.75%47.24%30.7%12.08%15.8%26.71%35.47%39.86%44.9%46.61%41.07%52.76%44.93%46.7%51.96%62.12%66.92%68.22%56.31%48.21%60.91%54.13%55.29%59.06%116.9%
Selling, General & Admin20.27M19.59M19.4M20.01M28.58M21.86M12.36M10.65M11.18M13.01M12.82M13.17M13.56M15.4M14.24M14.18M17.93M23.19M17.61M16.86M13.3M10.75M12.48M9.77M8.58M8.78M10.37M
SG&A % of Revenue-51.2%58.71%45.91%30.14%11.6%15.1%25.48%33.6%37.72%42.99%44.55%39.29%50.04%42.34%44.16%49.52%59.48%63.1%64.15%52.53%44.35%58%51.19%42.21%54.38%107.57%
Research & Development654.79K675.57K673.94K581.17K525.73K901.38K574.53K516.1K621.37K740.57K571.84K607.53K616.78K837.07K871.85K815.02K885.45K1.03M1.07M1.07M958.8K934.21K626.94K561.13K337.93K756.54K899.15K
R&D % of Revenue-1.77%2.04%1.33%0.55%0.48%0.7%1.23%1.87%2.15%1.92%2.06%1.79%2.72%2.59%2.54%2.44%2.64%3.82%4.07%3.79%3.85%2.91%2.94%1.66%4.69%9.33%
Other Operating Expenses1.82M000000000000000000000002.32M00
Operating Income-22.67M-20.22M-21.11M-11.49M-852.98K72.6M24.07M2.97M-1.32M-3.78M-3.51M-3.21M-2.16M-5.93M-3.94M-4.09M-6.78M-13.3M-10.44M-9.95M-6.71M-2.88M-8M-5.9M-6.39M-6.71M-10.45M
Operating Margin %-61.02%-52.84%-63.86%-26.35%-0.9%38.54%29.4%7.11%-3.97%-10.95%-11.76%-10.85%-6.25%-19.27%-11.71%-12.74%-18.72%-34.11%-37.44%-37.83%-26.51%-11.87%-37.17%-30.94%-31.45%-41.58%-108.33%
Operating Income Growth %-4.19%-83.71%-1246.84%-101.17%201.59%709.96%325.11%65.06%-7.74%-9.32%-48.68%63.62%-50.58%3.69%39.68%49%-27.29%-5.02%-48.12%-133.42%64.04%-35.51%7.62%4.83%35.72%-
EBITDA-14.88M-12.45M-13.54M-3.96M3.75M73.85M24.9M3.82M-433.38K-2.94M-2.63M-2.35M-1.08M-4.65M-2.6M-2.78M-5.26M-11.9M-9.05M-8.52M-5.29M-1.51M-6.7M-4.59M-5.06M-5.52M-9.51M
EBITDA Margin %-40.05%-32.55%-40.96%-9.09%3.95%39.2%30.42%9.15%-1.3%-8.53%-8.83%-7.95%-3.14%-15.09%-7.74%-8.65%-14.53%-30.52%-32.43%-32.39%-20.88%-6.23%-31.15%-24.08%-24.91%-34.17%-98.6%
EBITDA Growth %2.33%7.98%-241.72%-205.63%-94.92%196.56%551.24%982.35%85.28%-11.75%-12.12%-116.93%76.69%-78.52%6.3%47.23%55.76%-31.51%-6.24%-61.04%-250.24%77.48%-45.93%9.22%8.28%41.96%-
D&A (Non-Cash Add-back)7.79M7.77M7.57M7.53M4.6M1.26M832.07K852.08K886.81K834.95K872.87K858.39K1.07M1.28M1.34M1.31M1.52M1.4M1.4M1.43M1.43M1.37M1.29M1.31M1.33M1.2M938.57K
EBIT-8.16M-20.22M-3.4M-8.76M5.33M75.18M26.33M3.32M-1.18M-3.71M-3.48M4.54M-2.12M-5.89M-3.89M1.67M2.53M-13.24M-9.59M-9.95M-6.71M-2.88M-8M-5.9M-5.91M-6.71M-9.51M
Net Interest Income598.65K459.46K877.93K1.29M-160.7K39.28K132.48K184.27K-23.73K-145.07K-186.77K-194.75K-188.87K-191.63K-184.21K-177.89K-270.52K35.71K801.33K1.54M1.57M1.03M231.2K-262.59K-436.36K-501.67K419
Interest Income683.54K547.36K1M1.45M9.95K266.47K392.75K351.17K153.46K65.69K26.52K24.92K33.94K38.94K47K62.6K32.32K57.6K855.68K1.87M1.98M1.37M475.12K44.55K10.04K51.94K204.19K
Interest Expense84.89K87.9K122.5K152.17K170.65K227.18K260.26K166.9K177.19K210.76K213.29K219.67K222.81K230.58K231.21K240.48K302.84K21.89K54.36K326.3K411.15K339.69K243.92K307.14K446.39K553.62K203.78K
Other Income/Expense16.38M7.95M17.59M2.57M6.02M2.36M2M184.27K236.78K-145.07K-642.89K7.53M-188.87K-191.63K-184.21K5.52M8.64M-2.56M801.33K1.54M1.57M1.03M74.87M13.62M-436.36K0734.79K
Pretax Income-6.28M-12.27M-3.52M-8.92M5.16M74.95M26.07M3.16M-1.35M-3.92M-3.69M4.32M-2.35M-6.12M-4.12M1.43M2.22M-13.26M-9.64M-8.4M-5.15M-1.84M66.87M7.71M-6.83M00
Pretax Margin %-16.91%-32.08%-10.65%-20.45%5.44%39.79%31.85%7.55%-4.07%-11.37%-12.38%14.63%-6.8%-19.89%-12.25%4.46%6.14%-34.02%-34.57%-31.96%-20.33%-7.61%310.7%40.43%-33.6%--
Income Tax7.37K291.29K8.37M-1.91M83.87K18.89M1.85M7.88K-13.32K-187.61K1.13K7.88K8.18K90.97K9.82K13.8K-176.06K-3.84M0-1.45M-1.28M-605.36K12.18M265.47K0501.67K938.15K
Effective Tax Rate %-0.12%-2.37%-237.65%21.37%1.62%25.2%7.1%0.25%0.98%4.78%-0.03%0.18%-0.35%-1.49%-0.24%0.96%-7.91%28.94%0%17.3%24.86%32.83%18.21%3.44%0%--
Net Income-6.29M-12.57M-11.89M-7.01M5.08M56.06M24.22M3.15M-1.34M-3.74M-3.69M4.31M-2.35M-6.21M-4.13M1.42M2.4M-9.42M-9.64M-6.95M-3.87M-1.24M54.69M7.45M-6.83M-7.22M-10.44M
Net Margin %-16.93%-32.84%-35.97%-16.08%5.36%29.76%29.59%7.53%-4.03%-10.83%-12.39%14.6%-6.82%-20.18%-12.28%4.42%6.63%-24.17%-34.57%-26.43%-15.28%-5.11%254.12%39.04%-33.6%-44.69%-108.33%
Net Income Growth %72.43%-5.71%-69.54%-238.05%-90.94%131.45%669.42%334.95%64.13%-1.11%-185.64%283.23%62.11%-50.35%-391.36%-40.91%125.48%2.29%-38.79%-79.56%-212.48%-102.26%634.26%209.12%5.4%30.92%-
Net Income (Continuing)-6.29M-12.57M-11.89M-7.01M5.08M56.06M24.22M3.15M-1.34M-3.74M-3.69M4.31M-2.35M-6.21M-4.13M1.42M2.4M-9.42M-9.64M-6.95M-3.87M-1.24M54.69M7.45M-6.83M-7.22M-10.44M
Discontinued Operations000000000000000000000000000
Minority Interest000000000000000000000000000
EPS (Diluted)-0.21-0.43-0.40-0.240.151.630.800.07-0.04-0.12-0.130.20-0.09-0.23-0.160.020.04-0.40-0.41-0.29-0.16-0.052.330.20-0.34-0.36-0.54
EPS Growth %72.27%-7.5%-66.67%-260%-90.8%103.75%969.52%282.44%65.83%7.69%-165%332.56%62.61%-43.75%-900%-50%110%2.44%-41.38%-81.25%-201.32%-102.28%1065%158.82%5.56%33.33%-
EPS (Basic)--0.43-0.40-0.240.151.650.800.07-0.04-0.12-0.130.21-0.09-0.23-0.160.020.04-0.40-0.41-0.29-0.16-0.052.330.23-0.34-0.36-0.71
Diluted Shares Outstanding29.94M29.94M29.94M29.94M32.96M34.24M33.3M32.67M32.67M31.96M29.35M29.48M27.38M27M26.22M26.35M26.25M23.81M23.79M23.73M23.59M23.33M25.48M24.44M20.3M19.77M19.37M
Basic Shares Outstanding29.94M29.94M29.94M29.94M32.9M33.87M33.17M32.67M32.67M31.72M29.33M27.82M27.25M27M26.22M24.17M23.87M23.81M23.79M23.73M23.59M23.33M22.6M21M20.3M19.77M14.72M
Dividend Payout Ratio-----------------------6.16%---

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and operational insolvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Volatility Masks Structural Decline

As reported in recent financial filings, RVP's revenue trajectory remains highly erratic, with the most recent quarter showing a 13.5% year-over-year contraction, suggesting that the company struggles to maintain consistent commercial momentum outside of sporadic, lumpy government procurement cycles that fail to provide long-term growth durability.

The revenue profile appears heavily dependent on non-recurring orders, which complicates the assessment of underlying market demand for VanishPoint products. Investors should monitor whether the current contraction reflects a permanent loss of market share to larger, more diversified incumbents or merely a temporary lull in federal stockpiling activity.

Gross Margin Collapse Signals Distress

According to the company's latest income statement, gross margins have plummeted to a negligible 0.3%, indicating that the firm is effectively selling its core medical disposables at near-cost levels, likely due to a combination of intense pricing pressure and significant manufacturing inefficiencies at current production volumes.

This margin profile suggests a lack of pricing power, as the company appears unable to pass through rising raw material costs to its hospital and GPO customers. The inability to maintain healthy gross margins in a high-volume consumable business warrants further investigation into the viability of the current Texas-based manufacturing model.

Operating Leverage Remains Deeply Negative

Based on the provided quarterly data, RVP exhibits a persistent inability to achieve operating leverage, with SG&A expenses consistently exceeding gross profit, resulting in an operating margin of -85.9% in the most recent quarter as the company continues to burn through its remaining capital reserves.

The fixed nature of the company's SG&A costs, which remain stubbornly high despite revenue fluctuations, suggests that the current operational scale is insufficient to cover the overhead required to support the business. This structural imbalance implies that any future revenue growth may not necessarily lead to profitability without a fundamental reduction in the cost base.

Fixed Cost Burden Stifles Profitability

As indicated by the income statement, the company's cost structure is dominated by high fixed manufacturing and administrative expenses, which, when combined with a 0.3% gross margin, leaves virtually no room for error in managing the firm's limited liquidity and ongoing operational cash requirements.

The reliance on a domestic manufacturing footprint appears to be a significant drag on profitability, as the company lacks the scale to compete effectively with global peers on a cost-per-unit basis. Management's expense discipline appears insufficient to offset the impact of these high fixed costs, suggesting that the current business model may be unsustainable in its present form.

Solvency Risks Overshadow Potential Upside

While some may argue that RVP's domestic manufacturing capacity represents a strategic asset for future government contracts, the reality of the financials suggests a company facing a potential liquidity crisis, as evidenced by the consistent operating losses and the absence of any meaningful margin expansion.

Short-sellers would likely focus on the rapid depletion of cash reserves and the lack of a clear path to operational break-even. The market's current valuation may be ignoring the high probability of a dilutive capital raise, which could be necessary to sustain operations if the current cash burn rate continues.

RVP — Frequently Asked Questions

Quick answers to the most common questions about buying RVP stock.

What was Retractable Technologies, Inc.'s (RVP) revenue in 2025?

For fiscal year 2025, Retractable Technologies, Inc. (RVP) reported total revenue of $38.3M. This represents a 296.9% increase compared to $9.6M in 2000.

Is Retractable Technologies, Inc. (RVP) profitable?

Retractable Technologies, Inc. (RVP) reported a net loss of $12.6M for the fiscal year ending 2025.

What is Retractable Technologies, Inc.'s operating profit margin?

Retractable Technologies, Inc. (RVP) reported an operating income of $-20.2M, resulting in an operating profit margin of -52.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Retractable Technologies, Inc.'s gross profit and gross margin?

Retractable Technologies, Inc. (RVP) generated $0.0M in gross profit for the year, representing a gross profit margin of 0.1%. This demonstrates the company's core pricing power and production efficiency.